# Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia

> **NCT03774537** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Children's Hospital of Chongqing Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Transplantation of hUC-MSCs
- **DRUG:** No transplantation of hUC-MSCs

## Key facts

- **NCT ID:** NCT03774537
- **Lead sponsor:** Children's Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2019-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774537, "Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03774537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*